FDA could greenlight new Covid boosters as early as Friday. The boosters target XBB.1.5 omicron subvariant and will protect against current circulating subvariants. Concerns about slow rollout and potential delays. Boosters may receive full approval license. CDC recommendations and insurance coverage will determine distribution and accessibility. Novavax’s vaccine continues to be covered.
Holistic Health Blog